United States · FDA National Drug Code directory
ZEPOSIA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59572-820_4f94fc7c-c65f-6879-e063-6294a90a8217
- Product NDC
- 59572-820
- Form
- CAPSULE
- Composition / generic term
- ozanimod hydrochloride
- Labeler
- Celgene Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200327
- Source listing expiry
- 20271231
Source-listed ingredients
- OZANIMOD HYDROCHLORIDE — .92 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE, PLASTIC (59572-820-30) · 59572-820-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →